Author of the publication

Modifying immune responses to adeno-associated virus vectors by capsid engineering

, , , , , , , , , , and . Molecular Therapy-Methods & Clinical Development, (2023)

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

No persons found for author name Schoeder, Clara T
add a person with the name Schoeder, Clara T
 

Other publications of authors with the same name

RosettaCM for antibodies with very long HCDR3s and low template availability, , , , and . Proteins, 89 (11): 1458--1472 (November 2021)Computational structure prediction for antibody-antigen complexes from hydrogen-deuterium exchange mass spectrometry: Challenges and outlook, , , and . Front. Immunol., (May 2022)Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region, , , , , , , , , and 10 other author(s). PLoS Pathog., 18 (5): e1010518 (May 2022)Modifying immune responses to adeno-associated virus vectors by capsid engineering, , , , , , , , , and 1 other author(s). Molecular Therapy-Methods & Clinical Development, (2023)Structural comparative modeling of multi-domain F508del CFTR, , , , , , and . Biomolecules, 12 (3): 471 (March 2022)Backbone chemical shift and secondary structure assignments for mouse siderocalin, , , , and . Biomolecular NMR Assignments, 18 (1): 79--84 (2024)Combining Rosetta Sequence Design with Protein Language Model Predictions Using Evolutionary Scale Modeling (ESM) as Restraint, , and . ACS Synthetic Biology, 13 (4): 1085--1092 (2024)